| Literature DB >> 33766692 |
Yujiao Zu1, Ling Zhao2, Lei Hao1, Yehia Mechref3, Masoud Zabet-Moghaddam4, Peter A Keyel5, Mehrnaz Abbasi6, Dayong Wu7, John A Dawson8, Ruiwen Zhang9, Shufang Nie1, Naima Moustaid-Moussa1, Mikhail G Kolonin10, Alexes C Daquinag10, Luis Brandi11, Irfan Warraich11, Susan K San Francisco12, Xiaocun Sun13, Zhaoyang Fan14, Shu Wang15.
Abstract
Enhancing thermogenic energy expenditure via promoting the browning of white adipose tissue (WAT) is a potential therapeutic strategy to manage energy imbalance and the consequent comorbidities associated with excess body weight. Adverse effects and toxicities of currently available methods to induce browning of WAT have retarded exploration of this promising therapeutic approach. Targeted delivery of browning agents to adipose stromal cells (ASCs) in subcutaneous WAT to induce differentiation into beige adipocytes may overcome these barriers. Herein, we report for the first time, ASC-targeted delivery of trans-resveratrol (R), a representative agent, using ligand-coated R-encapsulated nanoparticles (L-Rnano) that selectively bind to glycanation site-deficient decorin receptors on ASCs. After biweekly intravenous administration of L-Rnano to obese C57BL/6 J mice for 5 weeks targeted R delivery significantly induced ASCs differentiation into beige adipocytes, which subsequently resulted in 40% decrease in fat mass, accompanied by improved glucose homeostasis and decreased inflammation. Our results suggest that the ASC-targeted nanoparticle delivery of browning agents could be a transformative technology in combating obesity and its comorbidities with high efficacy and low toxicity.Entities:
Keywords: Adipose stromal cells; Beige adipocytes; Nanoparticles; Obesity; trans-resveratrol
Mesh:
Substances:
Year: 2021 PMID: 33766692 PMCID: PMC8396108 DOI: 10.1016/j.jconrel.2021.03.022
Source DB: PubMed Journal: J Control Release ISSN: 0168-3659 Impact factor: 11.467